Targeted nanocarriers for cancer therapy

Porous silicon nanoparticles are very promising as a drug carrier thanks to their high porosity, biodegradability and biocompatibility. This project will explore the application of these nanocarriers to deliver chemo, gene and/or immune therapy to treat cancers using a range of preclinical cancer models including humanised tissue engineered cancer models that are highly predictive of performance in the clinic.

Enhanced research experiences